Servier Pharmaceuticals shared a post on LinkedIn:
“We are pleased to announce the appointment of Justin Cidado as Head of U.S. Research, expanding his leadership role as Servier continues to advance its oncology pipeline.
Since joining Servier five years ago, Justin has played a critical role in shaping our U.S. Research organization, leading cancer biology and helping drive the identification and progression of new oncology targets.
His leadership has been instrumental in strengthening our scientific foundation, from advancing early research programs to helping integrate and scale our research teams.
Please join us in congratulating Justin on this well-deserved appointment.
More posts about Servier Pharmaceuticals.